Investors

Pillar Bioscience’s investors are experienced industry leaders facilitating the most cutting-edge innovations in the health sciences. Thank you to our growing team of supporters.

Investors

ORI Capital

ORI Healthcare Fund L.P. is a $200 million venture capital fund focused on investing in innovative companies with disruptive technologies in the healthcare industry globally. The fund is founded by Ms. Simone Song, former Managing Director at Goldman Sachs.

Zhen Fund

A Beijing-based seed fund with a portfolio of over 150 high growth companies within technology. ZhenFund was established in 2011 in collaboration with Sequoia Capital China, with the aim of promoting innovation among youth in China. After empowering Chinese students to study abroad, Bob and Victor are now dedicated to helping returnees pursue entrepreneurship in China.

Shenzhen Oriental Fortune Capital Co Ltd.

A venture capital firm specializing investment in stages from early venture to mature capital raises. The firm typically invests in a broad consumer goods to telecommunications to healthcare, life sciences and pharmaceutical or biological medicine.

China Biotech Services Holdings, Ltd.

CBSH is a Hong Kong-based clinical testing company established in 1969 that has a third-party pathological testing lab (PHC), a broad brand awareness and a large network of customers and cooperative organizations in Hong Kong. The goal of CBSH is to deliver accurate disease detection to a vast patient population by developing a large health system with cutting-edge technologies and service distribution channels.

Start a relationship

Does Pillar Biosciences sound like part of your investment priority?
Contact us for more information about investment opportunities.

Pillar Biosciences logo white

Pillar Biosciences, Inc.
9 Strathmore Rd
Natick, MA 01760

 

Twitter Linkedin-in
© 2020 Pillar Biosciences | Privacy Policy
For research use only.
Not for diagnostic procedures unless otherwise stated.
WP Feedback

Dive straight into the feedback!
Login below and you can start commenting using your own user instantly

Scroll to Top